title: First line chemotherapy of metastatic breast cancer.
abstract: In the last 20-30 years the approach to metastatic breast cancer by chemotherapy has been largely studied. Anthracyclines, taxanes and, more recently, capecitabine and gemcitabine represent the breakthrough of treatment. In the next future the combination of chemotherapy and target therapy will be considered more frequently.
authors.affiliation: Department of Oncology, Felettino Hospital, La Spezia, Italy. ppronza@tin.it
authors.forename: P
authors.initials: P
authors.lastname: Pronzato
authors.forename: M
authors.initials: M
authors.lastname: Rondini
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology*; D017024:Chemotherapy, Adjuvant; D018734:Genes, erbB-2; D006801:Humans; D020360:Neoadjuvant Therapy; D009362:Neoplasm Metastasis; D013997:Time Factors